Ola Larsson

14.6k citations

136 papers · 10.2k indexed · 4 hit papers · h-index 50

Impact in

Molecular Biology top 0.5%
- PI3K/AKT/mTOR signaling in cancer
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
- RNA modifications and cancer
- Mitochondrial Function and Pathology
Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism

Papers in

Cancer Research 21
- Cancer, Hypoxia, and Metabolism 9
- Cancer-related molecular mechanisms research 8
Molecular Biology 87
- RNA and protein synthesis mechanisms 28
- RNA modifications and cancer 25
- RNA Research and Splicing 21
- PI3K/AKT/mTOR signaling in cancer 19
- Epigenetics and DNA Methylation 6

Co-authors: Ivan Topisirović Nahum Sonenberg Masahiro Morita Michaël Pollak Tommy Alain A. Zetterberg Claes Wahlestedt Barbara Cannon
Journals: Proceedings of the National Academy of Sciences (9 papers)Nucleic Acids Research (6 papers)PLoS ONE (4 papers)Cell Metabolism (3 papers)Nature Communications (3 papers)
Partner nations: Sweden Canada United States

In The Last Decade

Ola Larsson

125 papers receiving 10.1k citations

Hit Papers

align trajectories log scale

Fibrotic extracellular matrix activates a profibrotic positive feedback loop 2014 · 418 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 Journal of Clinical Investigation
2013 Cell Metabolism
2010 Science
2007 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Ola Larsson

Since Specialization

Citations

This map shows the geographic impact of Ola Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Larsson more than expected).

Fields of papers citing papers by Ola Larsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Larsson. The network helps show where Ola Larsson may publish in the future.

Co-authors

The 25 scholars most cited alongside Ola Larsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ola Larsson Line = papers co-authored together Ola Larsson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Control of protein synthesis through mRNA pseudouridylation by dyskerin Science Advances ·Wiyada Khangkhachit, Ewan Schafer, Dimitra Peirasmaki, Shan Chen, Sharon A. Savage, Ola Larsson, Jernej Ule, Laura Baranello, Federico Agostini, Marianne Farnebo	2023	19
2	The Role of Nonprofit Organizations in the Co-Production of Welfare Services: A Systematic Literature Review Ola Larsson	2023	0
3	MNK2 deficiency potentiates β-cell regeneration via translational regulation Nature Chemical Biology ·Christos Karampelias, Kathleen Watt, Charlotte L. Mattsson, 研駄馬中, 宮本智美, Jiarui Mi, Xiaojing Liu, Lianhe Chu, Jason W. Locasale, Gregory S. Korbutt, Meritxell Rovira, Ola Larsson, Olov Andersson	2022	18
4	PABP prevents the untimely decay of select mRNA populations in human cells The EMBO Journal ·RASOLOHERY Claudine A., Sahil Sharma, Shan Chen, David Dressler, 聡成石田, W Hildmann, Predrag Jovanović, Ola Larsson, Marc R. Fabian	2022	14
5	Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis The EMBO Journal ·Eric Kusnadi, Anna Trigos, Carleen Cullinane, David L. Goode, Ola Larsson, Jennifer R. Devlin, Keefe T. Chan, David P. De Souza, Malcolm J. McConville, Grant A. McArthur, George Thomas, Elaine Sanij, Gretchen Poortinga, Ross D. Hannan, Katherine M. Hannan, Jian Kang, Richard B. Pearson	2020	28
6	Generally applicable transcriptome-wide analysis of translation using anota2seq Nucleic Acids Research ·Christian Oertlin, Julie Lorent, Carl Murie, Luc Furic, Ivan Topisirović, Ola Larsson	2019	49
7	eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer JCI Insight ·David C. Muller, William Newmarch, Théo Goullet de Rugy, Rémi Samain, 祐輔川合, Marco Rodrigues, Hilal Yurtseven, Julie Guillermet‐Guibert, Christine Jean, Yoshinori Tsukumo, Nahum Sonenberg, Frédéric Marion, Nicolas Guilbaud, Jean‐Sèbastien Hoffmann, Ola Larsson, Corinne Bousquet, Stéphane Pyronnet, Yvan Martineau	2019	25
8	Enhanced translation expands the endo-lysosome size and promotes antigen presentation during phagocyte activation PLoS Biology ·Victoria E. B. Hipolito, Ayrton, Kristofferson Tandoc, Christian Oertlin, 彰布岡田, Neha Chauhan, Amra Sarić, Shannon McLaughlan, Ola Larsson, Ivan Topisirović, Roberto J. Botelho	2019	48
9	Distinct Cancer-Promoting Stromal Gene Expression Depending on Lung Function American Journal of Respiratory and Critical Care Medicine ·L Caroline, Laìa Masvidal, Carl Murie, Margarita Bartish, Svetlana Avdulov, LeeAnn Higgins, Todd W. Markowski, Mark S. Peterson, Jonas Bergh, Ping Yang, Charlotte Rolny, Andrew H. Limper, Timothy J. Griffin, Peter B. Bitterman, Chris H. Wendt, Ola Larsson	2019	18
10	mTORC1 and CK2 coordinate ternary and eIF4F complex assembly Nature Communications ·Valentina Gandin, Laìa Masvidal, Marie Cargnello, Laszlo Gyenis, Shannon McLaughlan, Yutian Cai, 博平山村, Masahiro Morita, Preetika Balanathan, Olivier Jean‐Jean, Vuk Stambolic, Matthias Trost, Luc Furic, Louise Larose, Antonis E. Koromilas, Katsura Asano, David W. Litchfield, Ola Larsson, Ivan Topisirović	2016	73
11	Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale Journal of Visualized Experiments ·Valentina Gandin, احمد عزمی زكی عبدالعزیز, Tommy Alain, Masahiro Morita, Shannon McLaughlan, Ola Larsson, Ivan Topisirović	2014	44
12	Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale Journal of Visualized Experiments ·Valentina Gandin, احمد عزمی زكی عبدالعزیز, Tommy Alain, Masahiro Morita, Shannon McLaughlan, Ola Larsson, Ivan Topisirović	2014	133
13	Translational control of immune responses: from transcripts to translatomes Nature Immunology ·Ciriaco A. Piccirillo, Eva Bjur, Ivan Topisirović, Nahum Sonenberg, Ola Larsson	2014	176
14	eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression Proceedings of the National Academy of Sciences ·Luc Furic, Liwei Rong, Ola Larsson, Ismaël Hervé Koumakpayi, Kaori Yoshida, Angxu Duan, Emmanuel Petroulakis, Nathaniel Robichaud, Michaël Pollak, Louis Gaboury, Pier Paolo Pandolfi, Fred Saad, Nahum Sonenberg	2010	398
15	mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs Science ·Ryan J.O. Dowling, Ivan Topisirović, Tommy Alain, Michael Bidinosti, Bruno D. Fonseca, Emmanuel Petroulakis, Xiaoshan Wang, Ola Larsson, Anand Selvaraj, Yi Liu, Sara C. Kozma, George Thomas, Nahum Sonenberg Hit paper breakdown →	2010	549
16	Eukaryotic Translation Initiation Factor 4E–Induced Progression of Primary Human Mammary Epithelial Cells along the Cancer Pathway Is Associated with Targeted Translational Deregulation of Oncogenic Drivers and Inhibitors Cancer Research ·Ola Larsson, Shunan Li, Avinash Hansada, Svetlana Avdulov, Mark S. Peterson, Karen Smith, Peter B. Bitterman, Vitaly A. Polunovsky	2007	132
17	Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages Proceedings of the National Academy of Sciences ·James A. Timmons, Kristian Wennmalm, Ola Larsson, Tomas B. Waldén, Timo Lassmann, Nataša Petrovič, D. Lee Hamilton, Ruth E. Gimeno, Claes Wahlestedt, Keith Baar, Jan Nedergaard, Barbara Cannon Hit paper breakdown →	2007	563
18	Digital Implementation of a Laser Doppler Perfusion Monitor KTH Publication Database DiVA (KTH Royal Institute of Technology) ·Ola Larsson	2006	1
19	The third sector and policy processes in Sweden : a centralised horizontal thirdsector policy community under strain London School of Economics and Political Science Research Online (London School of Economics and Political Science) ·克浅野, Z.H. CHEN, Ola Larsson, Jeremy Kendall	2005	5
20	Kinetics of Senescence-associated Changes of Gene Expression in an Epithelial, Temperature-sensitive SV40 Large T Antigen Model Cancer Research ·Ola Larsson, Camilla Schéele, Zicai Liang, N.J. HARDIMAN, Christina Karlsson, Claes Wahlestedt	2004	22

About Ola Larsson

Ola Larsson is a scholar working on Cancer Research, Molecular Biology, Public Administration, Oncology and Cell Biology, having authored 136 papers that have together received 10.2k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (28 papers), RNA modifications and cancer (25 papers), RNA Research and Splicing (21 papers), PI3K/AKT/mTOR signaling in cancer (19 papers), Cancer, Hypoxia, and Metabolism (9 papers), Cancer-related molecular mechanisms research (8 papers), Adipose Tissue and Metabolism (7 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Molecular Biology (6.7k citations), Cancer Research (1.4k citations), Aging (115 citations), Physiology (1.6k citations) and Immunology (1.3k citations). Ola Larsson has collaborated with scholars based in Sweden, Canada and United States. Frequent co-authors include Ivan Topisirović, Nahum Sonenberg, Masahiro Morita, Michaël Pollak, Tommy Alain, A. Zetterberg, Claes Wahlestedt, Barbara Cannon, Jan Nedergaard and Julie St‐Pierre. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research, PLoS ONE, Cell Metabolism and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact